多基因风险评分增强模型对冠心病的预测准确性
联合模型的C统计量为0.78,较汇总队列方程的0.76仅提高0.02,净重分类改善整体为4.0%,提示增量预测价值有限。
要点
- 多基因风险评分联合汇总队列方程使C统计量从0.76升至0.78,提升幅度小。
- 在7.5%风险阈值下,联合模型整体净重分类改善为4.0%。
- 汇总队列方程存在高估风险,重新校准后可纠正。
核心结论
- 在汇总队列方程基础上加入冠心病多基因风险评分,对冠心病发病预测准确性有统计学显著但幅度有限的改善,仅使小部分个体风险分层得到优化。
主要发现
- 评估队列中位随访8年,发生6272例 incident 冠心病事件。
- 多基因风险评分、汇总队列方程及联合模型的C统计量分别为0.61(95%CI 0.60-0.62)、0.76(95%CI 0.75-0.77)、0.78(95%CI 0.77-0.79)。
- 联合模型与汇总队列方程的C统计量变化为0.02(95%CI 0.01-0.03)。
- 汇总队列方程校准显示高估风险,重新校准后纠正。
关键数值与推荐
- 使用7.5%风险阈值,联合模型对病例的净重分类改善为4.4%(95%CI 3.5%-5.3%),对非病例为-0.4%(95%CI -0.5%至-0.4%),整体净重分类改善为4.0%(95%CI 3.1%-4.9%)。
临床怎么用
- 多基因风险评分联合汇总队列方程仅带来小幅预测改善,临床推广应用前需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The incremental value of polygenic risk scores in addition to well-established risk prediction models for coronary artery disease (CAD) is uncertain. OBJECTIVE: To examine whether a polygenic risk score for CAD improves risk prediction beyond pooled cohort equations. DESIGN, SETTING, AND PARTICIPANTS: Observational study of UK Biobank participants enrolled from 2006 to 2010. A case-control sample of 15 947 prevalent CAD cases and equal number of age and sex frequency-matched controls was used to optimize the predictive performance of a polygenic risk score for CAD based on summary statistics from published genome-wide association studies. A separate cohort of 352 660 individuals (with follow-up to 2017) was used to evaluate the predictive accuracy of the polygenic risk score, pooled cohort equations, and both combined for incident CAD. EXPOSURES: Polygenic risk score for CAD, pooled cohort equations, and both combined. MAIN OUTCOMES AND MEASURES: CAD (myocardial infarction and its related sequelae). Discrimination, calibration, and reclassification using a risk threshold of 7.5% were assessed. RESULTS: In the cohort of 352 660 participants (mean age, 55.9 years; 205 297 women [58.2%]) used to evaluate the predictive accuracy of the examined models, there were 6272 incident CAD events over a median of 8 years of follow-up. CAD discrimination for polygenic risk score, pooled cohort equations, and both combined resulted in C statistics of 0.61 (95% CI, 0.60 to 0.62), 0.76 (95% CI, 0.75 to 0.77), and 0.78 (95% CI, 0.77 to 0.79), respectively. The change in C statistic between the latter 2 models was 0.02 (95% CI, 0.01 to 0.03). Calibration of the models showed overestimation of risk by pooled cohort equations, which was corrected after recalibration. Using a risk threshold of 7.5%, addition of the polygenic risk score to pooled cohort equations resulted in a net reclassification improvement of 4.4% (95% CI, 3.5% to 5.3%) for cases and -0.4% (95% CI, -0.5% to -0.4%) for noncases (overall net reclassification improvement, 4.0% [95% CI, 3.1% to 4.9%]). CONCLUSIONS AND RELEVANCE: The addition of a polygenic risk score for CAD to pooled cohort equations was associated with a statistically significant, yet modest, improvement in the predictive accuracy for incident CAD and improved risk stratification for only a small proportion of individuals. The use of genetic information over the pooled cohort equations model warrants further investigation before clinical implementation.
引用
- Elliott J, Bodinier B, Bond TA, et al. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. JAMA. 2020. PMID: 32068818. doi:10.1001/jama.2019.22241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。